Lin, Richard J. http://orcid.org/0000-0002-0834-7880
Sanchez, Matias
Abbi, Kamal
Devlin, Sean M.
Jakubowski, Ann A.
Papadopoulos, Esperanza B.
Barker, Juliet N.
Tamari, Roni
Young, James W.
Gyurkocza, Boglarka
Ponce, Doris M.
Dahi, Parastoo B.
Maloy, Molly A.
Giralt, Sergio A.
Perales, Miguel-Angel
Castro-Malaspina, Hugo
Article History
Received: 26 July 2019
Revised: 7 October 2019
Accepted: 9 October 2019
First Online: 23 October 2019
Compliance with ethical standards
:
: Dr Giralt reports research funding from Amgen, Actinium, Celgene, Johnson & Johnson, Miltenyi Biotec, and Takeda and serves as a consultant for Amgen, Actinium, Celgene, Johnson & Johnson, Jazz Pharmaceuticals, Miltenyi Biotec, Takeda, Novartis, Kite Pharma, and Spectrum Pharmaceuticals. Dr Perales reports honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. He has also received research support for clinical trials from Incyte and Miltenyi Biotec. All other authors declare that they have no conflict of interest.